BRPI0821034A2 - Vírus influenza modificado - Google Patents

Vírus influenza modificado

Info

Publication number
BRPI0821034A2
BRPI0821034A2 BRPI0821034-9A BRPI0821034A BRPI0821034A2 BR PI0821034 A2 BRPI0821034 A2 BR PI0821034A2 BR PI0821034 A BRPI0821034 A BR PI0821034A BR PI0821034 A2 BRPI0821034 A2 BR PI0821034A2
Authority
BR
Brazil
Prior art keywords
influenza virus
modified influenza
modified
virus
influenza
Prior art date
Application number
BRPI0821034-9A
Other languages
English (en)
Inventor
Christian Kittel
Nina Wressnigg
Original Assignee
Avir Green Hills Biotechnology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avir Green Hills Biotechnology filed Critical Avir Green Hills Biotechnology
Publication of BRPI0821034A2 publication Critical patent/BRPI0821034A2/pt
Publication of BRPI0821034A8 publication Critical patent/BRPI0821034A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0821034A 2007-12-21 2008-12-22 Vírus influenza b recombinante, seu uso, metodo de preparação, composição de vacina o contendo e seu gene m, bem como ácido nucléico isolado, molécula do vírus influenza m e seu uso e método para aumentar a taxa de crescimento de vírus influenza b deficiente de replicação BRPI0821034A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07450244A EP2072058A1 (en) 2007-12-21 2007-12-21 Modified influenza virus
PCT/EP2008/068154 WO2009080806A2 (en) 2007-12-21 2008-12-22 Modified influenza virus

Publications (2)

Publication Number Publication Date
BRPI0821034A2 true BRPI0821034A2 (pt) 2015-06-16
BRPI0821034A8 BRPI0821034A8 (pt) 2016-12-13

Family

ID=39325504

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0821034A BRPI0821034A8 (pt) 2007-12-21 2008-12-22 Vírus influenza b recombinante, seu uso, metodo de preparação, composição de vacina o contendo e seu gene m, bem como ácido nucléico isolado, molécula do vírus influenza m e seu uso e método para aumentar a taxa de crescimento de vírus influenza b deficiente de replicação

Country Status (11)

Country Link
US (1) US8592196B2 (pt)
EP (2) EP2072058A1 (pt)
JP (1) JP2011505863A (pt)
KR (1) KR101597633B1 (pt)
CN (1) CN101903043B (pt)
AU (1) AU2008339972A1 (pt)
BR (1) BRPI0821034A8 (pt)
CA (1) CA2705444C (pt)
EA (1) EA024036B1 (pt)
MX (1) MX2010006918A (pt)
WO (1) WO2009080806A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011156273A1 (en) * 2010-06-06 2011-12-15 Mount Sinai School Of Medicine Recombinant rna viruses and uses thereof
KR101315273B1 (ko) * 2012-10-29 2013-10-08 대한민국 강독화된 인플루엔자 바이러스 변이주
CN104436157A (zh) 2013-09-23 2015-03-25 恩金生物有限公司 流感疫苗和治疗
US10080792B2 (en) 2013-09-23 2018-09-25 Engen Bio, Inc. Influenza vaccine and therapy
KR101582490B1 (ko) 2014-04-14 2016-01-19 아이디바이오 주식회사 인플루엔자 바이러스의 다중 아형에 대한 교차 면역반응을 형성하는 신규한 재조합 바이러스 백신
US9827304B2 (en) * 2014-11-13 2017-11-28 The University Of Hong Kong Live attenuated vaccines for influenza viruses
RU2628690C2 (ru) * 2015-11-06 2017-08-21 Общество С Ограниченной Ответственностью 'Фарминтерпрайсез' Аттенуированные гриппозные векторы для профилактики и/или лечения инфекционных заболеваний, а также для лечения онкологических заболеваний
TWI793059B (zh) * 2016-04-13 2023-02-21 香港商港大科橋有限公司 用於流感病毒的減弱活疫苗
WO2018157047A1 (en) * 2017-02-27 2018-08-30 Flugen, Inc. Influenza b virus mutants and uses therefor
BR112020012241A2 (pt) 2017-12-22 2020-11-24 Codagenix Inc. vírus recombinante com a região não otimizada com codon-par e usos para o tratamento do câncer
US12168049B2 (en) 2018-03-08 2024-12-17 Codagenix Inc. Attenuated flaviviruses
CA3119857A1 (en) * 2018-11-16 2020-05-22 Versitech Limited Live attenuated influenza b virus compositions methods of making and using thereof
US12350325B2 (en) 2019-01-24 2025-07-08 Vivaldi Biosciences Inc. Recombinant high growth rate influenza virus comprising mutations in M1, NS2, and PB2
KR102370100B1 (ko) 2019-02-15 2022-03-07 아이디바이오 주식회사 이종 인플루엔자 a 바이러스에 대한 면역/치료반응을 형성하는 신규한 재조합 인플루엔자 바이러스 및 이를 포함하는 유전자 전달체 및 치료백신

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999064571A1 (en) 1998-06-12 1999-12-16 Mount Sinai School Of Medicine Of The City University Of New York Interferon inducing genetically engineered attenuated viruses
DK1085904T3 (da) * 1998-06-12 2013-02-25 Sinai School Medicine Svækkede minusstreng-vira med ændret interferon-antagonist-aktivitet til anvendelse som vacciner og lægemidler
KR101190932B1 (ko) * 2003-02-25 2012-10-16 메디뮨 엘엘씨 인플루엔자 백신 조성물의 제조 방법
AT502292B1 (de) 2005-05-11 2010-04-15 Avir Green Hills Biotechnology Melanomdiagnose
US20070116717A1 (en) * 2005-08-01 2007-05-24 Shneider Alexander M Influenza vaccine compositions and methods
CN1810961B (zh) * 2006-02-22 2010-05-12 中国人民解放军军事医学科学院微生物流行病研究所 一种重组流感病毒及其制备方法与应用
EP2049662A4 (en) * 2006-07-21 2009-12-30 Medimmune Llc METHODS AND COMPOSITIONS FOR INCREASING REPLICATION CAPACITY OF A FLU VIRUS
EP2045323A1 (en) 2007-10-05 2009-04-08 Avir Green Hills Biotechnology Research Development Trade Ag Linear expression constructs for production of influenza virus particles
EP2048237A1 (en) 2007-10-05 2009-04-15 Avir Green Hills Biotechnology Research Development Trade Ag Replication deficient Influenza virus for the expression of heterologous sequences

Also Published As

Publication number Publication date
CA2705444A1 (en) 2009-07-02
US20100322970A1 (en) 2010-12-23
AU2008339972A1 (en) 2009-07-02
EP2222334B1 (en) 2014-05-21
MX2010006918A (es) 2010-12-06
EA201001045A1 (ru) 2010-12-30
WO2009080806A2 (en) 2009-07-02
CA2705444C (en) 2017-04-25
JP2011505863A (ja) 2011-03-03
KR101597633B1 (ko) 2016-02-26
BRPI0821034A8 (pt) 2016-12-13
EP2072058A1 (en) 2009-06-24
CN101903043B (zh) 2014-01-22
US8592196B2 (en) 2013-11-26
CN101903043A (zh) 2010-12-01
WO2009080806A3 (en) 2009-10-08
EA024036B1 (ru) 2016-08-31
EP2222334A2 (en) 2010-09-01
KR20100102593A (ko) 2010-09-24

Similar Documents

Publication Publication Date Title
BRPI0821034A2 (pt) Vírus influenza modificado
DK3192874T3 (da) Virusoprensning
ATE450271T1 (de) Impfstoff
DK2049559T3 (da) Forbedrede HPV vacciner
BRPI0922878A2 (pt) ventilador
DK2114993T3 (da) Vaccine
DK2242752T3 (da) Imidazolyl-biphenylimidazoler som hepatitis C-virus-inhibitorer
BRPI0908240A2 (pt) inibidores do vírus da hepatite c
BRPI0907733A2 (pt) Inibidores do vírus da hepatite c
IL239023A0 (en) Neutralizing antibodies to influenza viruses
HRP20170963T1 (hr) Modificirani saharidi
CR10571A (es) Vacuna virica recombinante
BRPI0920521A2 (pt) combinação farmacêutica
DK2200646T3 (da) RNA-Vacciner
BRPI1010506A2 (pt) "inibidores do vírus da hepatite c"
EP2111418A4 (en) Hollow microparticles
DK2043682T3 (da) Influenzavaccine
ZA200809056B (en) Influenza virus vaccine
FI20090030A0 (fi) Onkolyyttiset virukset
BRPI0914245A2 (pt) Endolisina plyp40
BRPI0921578A2 (pt) vacinas unitemporais
BRPI0923034A2 (pt) terapia de combinação para virus da hepatite c
SE0950024L (sv) Skorsten
DK2175881T3 (da) Intradermal influenzavaccine
EP2220376A4 (en) Fan

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BAXTER HEALTHCARE S.A (CH)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]